Renaissance Technologies
CURX

Renaissance Technologies’s Curanex Pharmaceuticals CURX Stock Holding History

Renaissance Technologies’s Portfolio CURX Stock Details CURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8K Buy
+2,600
New +$18.9K ﹤0.01% 3117
2026
Q1 		– Sell
-2,965
Closed -$19.6K – 3801
2025
Q4 		$19.6K Buy
+2,965
New +$32.6K ﹤0.01% 3148

Other funds holding CURX

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Renaissance Technologies's CURX Position: Q2 2026 in Review

Renaissance Technologies opened a new position in Curanex Pharmaceuticals (CURX) in Q2 2026: 2,600 shares worth $13.8K. The stake represents ﹤0.01% of the portfolio and ranks #3117 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in CURX as recently as Q4 2025.

Renaissance Technologies first reported a position in CURX in Q4 2025 and has held it in 2 quarters since. The position peaked at $19.6K in Q4 2025. 11 funds tracked by Wall St. Rank hold CURX as of Q2 2026.

  • Renaissance Technologies held 2,600 shares of Curanex Pharmaceuticals worth $13.8K as of Q2 2026.
  • Curanex Pharmaceuticals was a new Renaissance Technologies position in Q2 2026.
  • Curanex Pharmaceuticals made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3117 holding.
  • Renaissance Technologies first reported a position in Curanex Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Renaissance Technologies's Curanex Pharmaceuticals position peaked at $19.6K in Q4 2025.
  • 11 funds tracked by Wall St. Rank held Curanex Pharmaceuticals as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.